(603858)"Shandong Buchang Pharmaceuticals Co., Ltd."Announcement on Obtaining Drug Registration Certificate
Filed with SSE · Stock code 603858 · · 2 pages · Chinese
Summary by 6ix AI
Shandong Buchang Pharmaceuticals Co., Ltd. has announced the receipt of a drug registration certificate for a specific oral solution from the National Medical Products Administration.
Written in English by 6ix AI from the company’s Chinese-language filing. How 6ix writes summaries
Shandong Buchang Pharmaceuticals Co., Ltd. on 6ix
Story so far
Earlier from Shandong Buchang Pharmaceuticals
- (603858)"Shandong Buchang Pharmaceuticals Co., Ltd."Announcement on Signing of Technology Transfer Contract by Wholly-owned Subsidiary
- (603858)"Shandong Buchang Pharmaceuticals Co., Ltd."Announcement on Resolutions of the 57th Meeting of the 5th Board of Directors
- (603858)"Shandong Buchang Pharmaceuticals Co., Ltd."Announcement on Proposed External Investment by Controlled Subsidiary for Establishment of Wholly-owned Subsidiary
- (603858)"Shandong Buchang Pharmaceuticals Co., Ltd."Announcement on Cooperative Investment with Private Fund
- Announcement on Capital Increase and Share Expansion of Controlled Subsidiary for Introduction of External Investors, the Company's Waiver of Preemptive Subscription Rights, and Related Party Transactions
Later from Shandong Buchang Pharmaceuticals
- (603858)"Shandong Buchang Pharmaceuticals Co., Ltd."Announcement on the Profit Distribution Plan for the First Half of 2026
- (603858)"Shandong Buchang Pharmaceuticals Co., Ltd."Announcement on Approval of Marketing Authorization for Qianlie Shutong Capsules in Indonesia
Follow Shandong Buchang Pharmaceuticals into a list and get an email when it puts out news.
Follow Shandong Buchang Pharmaceuticals